Tessera Defense & Homeland Security HLSQ
NYSE HLSQ
$0.35 -0.03 (-7.89%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tessera Defense & Homeland Security (HLSQ) Return on Capital Employed [ROCE] (2019 - 2026)

Updated

Tessera Defense & Homeland Security (HLSQ) reported Return on Capital Employed [ROCE] of -595.59% for Q2 2026, down 474.21 percentage points from -121.39% a year earlier but up 1095.52 percentage points from the prior quarter.

Analysis

Tessera Defense & Homeland Security (HLSQ) Return on Capital Employed [ROCE] (2019 - 2026) Analysis & Trends

For FY2025, Tessera Defense & Homeland Security posted Return on Capital Employed [ROCE] of -228.73%, down 56.58 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has declined for three consecutive years, with a five-year change of -187.88 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -172.14% in FY2024 (-66.98 pp), -105.16% in FY2023 (-54.59 pp), -50.57% in FY2022 (+5.60 pp) and -56.17% in FY2021 (-15.33 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -1691.11% in Q1 2026 and a high of -43.62% in Q2 2024.
  • Year over year, Return on Capital Employed [ROCE] has now declined in each of the last six quarters, with an average year-over-year change of -314.70 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q3 2024 (a gain of 45.38 percentage points); the low point was Q1 2026 (a drop of 1569.54 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -1691.11% (Q1 2026), -432.10% (Q4 2025) and -150.32% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Tessera Defense & Homeland Security 360,957.79 -5.90 Mn 97,000.00 -595.59%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -595.59%
Mar 31, 2026 -1,691.11%
Dec 31, 2025 -432.10%
Sep 30, 2025 -150.32%
Jun 30, 2025 -121.39%
Mar 31, 2025 -121.57%
Dec 31, 2024 -102.73%
Sep 30, 2024 -59.81%
Jun 30, 2024 -43.62%
Mar 31, 2024 -60.84%
Dec 31, 2023 -141.87%
Sep 30, 2023 -105.19%
Jun 30, 2023 -82.22%
Mar 31, 2023 -77.07%
Dec 31, 2022 -66.75%
Sep 30, 2022 -65.97%
Jun 30, 2022 -60.85%
Mar 31, 2022 -54.64%
Dec 31, 2021 -51.51%
Sep 30, 2021 -55.39%
API Access

Tessera Defense & Homeland Security Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=HLSQ&period=max&api_key=YOUR_API_KEY